—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Gerresheimer AG (GXI.DE) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for GXI.DE, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-25

DayWeekMonth3 months
GXI.DE−0.5%−3.2%−1.8%−6.4%
Longevity & Healthspan−0.3%+4.5%+0.5%—
HALO Growth 1000.0%+0.2%−7.6%—

Against the index: 3.4 pts behind on the week, 5.8 pts ahead on the month; against its Longevity & Healthspan sleeve 2.3 pts behind on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sector × region Health care in Europe: +0.1% week · −3.6% month · −4.6% quarter · −2.4% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-26
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
Who it is priced against HALO Growth 100 · Longevity & Healthspan · 8 names with week and year-to-date

Peer group

HALO Growth 100 · Longevity & Healthspan

GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.

Compared against GXI.DE on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Gerresheimer AG

GXI.DE in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Gerresheimer makes containers and delivery devices that hold and administer drugs: prefillable syringes, vials, ampoules, plastic packaging, inhalers and injector pens, built across plastics, glass and advanced-technology divisions. It also supplies diagnostic hardware, cosmetic packaging and contract manufacturing for drug-delivery programmes. Its customers span pharmaceutical, biotech, diagnostic, cosmetic and food-and-beverage makers, and it is based in Düsseldorf.
Where it sits in the stack
Gerresheimer carries no seat in Rubin, our AI build-out index, so it sits outside that stack entirely. It belongs to HALO Growth 100, our growth index for names outside the megacaps, in the Longevity & Healthspan sleeve, where demand tracks demographics rather than compute.
Who it is priced against
Its peer group in the diary sits inside Longevity & Healthspan, alongside GLP-1 leaders, gene-editing platforms, diagnostics-at-scale and biopharma compounders such as Eli Lilly, Novo Nordisk, Regeneron, Vertex, Illumina and Amgen; the market also names Stevanato Group as a direct comparison in drug-containment hardware.
Why Closelooknet tracks it
It holds a seat in HALO Growth 100 and carries a Closelooknet score across our seven modules, with momentum reading strongest and quality reading weakest; the diary has not yet quoted it in an edition.
What the diary watches
Whether the quality module recovers from its current weak reading, since that gap sits furthest from the strength the momentum module currently shows.

Gerresheimer AG (GXI.DE) trades on the XETRA exchange in Germany, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 33/100 composite (momentum 51, quality 7, valuation 58) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.15%, annual · last 0.0400 EUR on 2026-06-05

Dividends and capital return

What GXI.DE pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.0400 EUR per share · a 0.15% yield on the 2026-09-25 close 1 distribution, paid once a year 2026-09-25
  • Change on the year 0.0% against the prior twelve months prior twelve months 0.0400 EUR per share
  • Last distribution 0.0400 EUR per share as the price series records it, within days of the ex-date 2026-06-05
  • By calendar year 2024: 1.25 EUR (partial) · 2025: 0.0400 EUR · 2026: 0.0400 EUR to date first distribution recorded in the three-year window: 2024-06-06
  • Dividends paid, FY2025 2 m EUR 6% of earnings
  • Share count +0.0% in FY2025
  • Capital returned 2 m EUR in a year of negative free cash flow dividends and buybacks together

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Gerresheimer AG (GXI.DE)?

Gerresheimer AG trades as GXI.DE on the XETRA exchange (Germany) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is GXI.DE in a Closelooknet index?

Yes — Gerresheimer AG is a constituent of HALO Growth 100, as of 2026-09-26.

What is Gerresheimer AG's Closelooknet composite score?

33 out of 100, with momentum 51, quality 7 and valuation 58 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does GXI.DE trade against its moving averages?

Stochastic turned up: Its stochastic crossed up out of oversold (%K 10.1 over %D 8) 2 sessions ago — a short-term momentum-turn signal. As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is GXI.DE doing against its Closelooknet index?

Over the past month Gerresheimer AG is −1.8% against −7.6% for the HALO Growth 100 — 5.8 points ahead of its index, as of 2026-09-25. Its Longevity & Healthspan sleeve is +0.5% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Gerresheimer AG do?

Gerresheimer makes containers and delivery devices that hold and administer drugs: prefillable syringes, vials, ampoules, plastic packaging, inhalers and injector pens, built across plastics, glass and advanced-technology divisions. It also supplies diagnostic hardware, cosmetic packaging and contract manufacturing for drug-delivery programmes. Its customers span pharmaceutical, biotech, diagnostic, cosmetic and food-and-beverage makers, and it is based in Düsseldorf. Its peer group in the diary sits inside Longevity & Healthspan, alongside GLP-1 leaders, gene-editing platforms, diagnostics-at-scale and biopharma compounders such as Eli Lilly, Novo Nordisk, Regeneron, Vertex, Illumina and Amgen; the market also names Stevanato Group as a direct comparison in drug-containment hardware.

Where does Gerresheimer AG sit in the AI build-out?

Gerresheimer carries no seat in Rubin, our AI build-out index, so it sits outside that stack entirely. It belongs to HALO Growth 100, our growth index for names outside the megacaps, in the Longevity & Healthspan sleeve, where demand tracks demographics rather than compute. It holds a seat in HALO Growth 100 and carries a Closelooknet score across our seven modules, with momentum reading strongest and quality reading weakest; the diary has not yet quoted it in an edition.

Does Gerresheimer AG pay a dividend?

Gerresheimer AG has paid 0.0400 EUR per share over the last twelve months, paid once a year, a trailing yield of 0.15% on the 2026-09-25 close; the last distribution recorded in the price series was 0.0400 EUR on 2026-06-05. In fiscal 2025 the company paid 2 m EUR in dividends. The share count rose 0.0% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for GXI.DE, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Instruments & Supplies. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.